The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial
OncologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Annals of surgical oncology
- Publicado em
- 14 dez 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial
A W J Beerthuizen, T I M Snellen, S A Bartels, A Kuijer, C Poncet, C A Drukker, E J T Rutgers, M J T F D Vrancken Peeters, F H van Duijnhoven
Descritores MeSH
- Breast Neoplasms
- Lymph Nodes
- Axilla
- Female
- Follow-Up Studies
- Humans
- Lymph Node Excision
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Staging
Veja também
Estudos relacionados
- Clinicopathologic characteristics and lymph node status in the NAUTILUS clinical trial:KBCSG-21
- AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026
- Targeted axillary dissection in the primary surgery setting for node-positive breast cancer: A systematic review
- Omission of axillary surgery in early breast cancer with negative lymph nodes: a systematic review and meta-analysis of randomized clinical trials